Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2077-2025Class II

ColoSense Test Kit, Part No. 80-001, component of ColoSense test

Geneoscopy, Inc. / initiated 2025-05-20 / Open, Classified

Geneoscopy, Inc. began a recall of ColoSense Test Kit, Part No. 80-001, component of ColoSense test on . FDA classified it as Class II and gives the reason as "Multiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2077-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Geneoscopy, Inc.
Product
ColoSense Test Kit, Part No. 80-001, component of ColoSense test
Product code
SBB System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
Reason for recall
Multiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit.
FDA root cause
Unknown/Undetermined by firm
Action
On May 20, 2025, the firm initiated a voluntary removal of the affected test kit lot. An internal recall notification was sent to the affected CLIA Laboratory Director. All remaining test kits were removed from the CLIA laboratory. The firm's investigation of the root cause for this issue is ongoing.
Quantity in commerce
10 units
Distribution
US Nationwide distribution in the state of Missouri.
Product codes and lots
Lot number 80-001-A2501

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2077-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2077-2025Class IIOngoingVoluntary: Firm initiated